Australian Osteoporosis Therapeutics Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Osteoporosis is characterised by low bone mass and structural deterioration of bone tissue, causing increased susceptibility to fractures and chronic bone pain. The main therapies for the treatment of osteoporosis are hormone replacement therapy (HRT), bisphosphonates and selective oestrogen receptor modulators (SERMs). A key driver for the market is the lack of effective drugs that have a good safety and side effect profile. With a few drugs expected to enter the market over the forecast period, competition is expected to intensify. Stratification of the market should happen, so that companies should be able to serve niche markets. The current leader however, is expected to remain the dominant provider of osteoporosis medications.

Table of Contents

Australian Osteoporosis Therapeutics Markets, Australian Osteoporosis Therapeutics Markets Executive SummaryMarket Overview Competitive AnalysisIndustry Issues and Challenges Market Opportunities and ForecastsStrategic ConclusionsAustralian Osteoporosis Therapeutics Markets, Research Agenda and Total MarketScope and Segmentation Scope and Segmentation Research Methodology Disease IntroductionMarket DynamicsDemand AnalysisFactors Affecting Market GrowthMarket Drivers Market ChallengesRevenue Forecast Frost & Sullivan Awards for the Australian Osteoporosis Market2005 Frost & Sullivan AwardsAustralian Osteoporosis Therapeutics Markets, Trends and Products for the Treatment of OsteoporosisBisphosphonates Bisphosphonates Market Drivers Market Restraints Competitive Structure Competitive FactorsChallenges for the SERMs Market Challenges for the SERMs Market Market DriversMarket Restraints Competitive StructureProduct Analysis Challenges facing the Australian PTH marketChallenges Facing the Australian PTH MarketMarket Drivers Market Restraints Competitive Structure Product AnalysisAustralian Osteoporosis Therapeutics Markets, Competitive Landscape Competitive Structure Competitive Structure Competitive FactorsMarket Share Analysis Pipeline Analysis Australian Osteoporosis Therapeutics Markets, Strategic RecommendationsStrategic RecommendationsApplication for Listing as a Therapeutic on the Pharmaceutical Benefits Scheme (PBS) Australian Osteoporosis Therapeutics Markets, Appendix Definition Definition Population GrowthThe Therapeutics Goods Administration (TGA)Listing on the Pharmaceutical Benefits Scheme (PBS)References




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : Asia Pacific

Release Date : 15-Nov-17

Region : Asia Pacific

Release Date : 14-Nov-17

Region : Asia Pacific

Release Date : 14-Nov-17

Region : Asia Pacific

Release Date : 14-Nov-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.